Effect of premature menopause on sexuality

Women's Health

Volumn 3, Issue 4, 2007, Pages 455-474

  Graziottin, Alessandra ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Arousal disorders; Cancer survivors; Desire disorders; Dyspareunia; Estrogen; Hormone therapy; Infertility; Premature menopause; Sexual dysfunction; Testosterone

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTINEOPLASTIC AGENT; CONJUGATED ESTROGEN; CORTISONE; CYCLOPHOSPHAMIDE; ESTRADIOL; ESTROGEN; FLUOROURACIL; GABAPENTIN; GOSERELIN; METHOTREXATE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; PREGABALIN; SEX HORMONE; TESTOSTERONE; TIBOLONE;

ADJUVANT THERAPY; AGE; AMENORRHEA; ASTHENIA; BEHAVIOR THERAPY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CELL PROTECTION; CHILDHOOD CANCER; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; COPING BEHAVIOR; CRYOPRESERVATION; CULTURAL FACTOR; DEPRESSION; DISEASE ASSOCIATION; DRUG INDICATION; DYSPAREUNIA; EARLY MENOPAUSE; ENDOMETRIOSIS; ETHNICITY; FEEDBACK SYSTEM; FEMALE FERTILITY; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FEMININITY; FRAGILE X SYNDROME; GALACTOSEMIA; GENDER IDENTITY; HEMATOLOGIC MALIGNANCY; HORMONAL THERAPY; HUMAN; INDIVIDUALIZATION; LIBIDO; MALIGNANT NEOPLASTIC DISEASE; MASSAGE; MASTURBATION; MEDICAL ASSESSMENT; MENSTRUATION DISORDER; MOTIVATION; MULTIPLE CYCLE TREATMENT; OOCYTE; ORGASM; ORGASM DISORDER; OVARIECTOMY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SAFETY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PSYCHOTHERAPY; REVIEW; SELF CONCEPT; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; SOCIAL ASPECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TURNER SYNDROME; VAGINAL DRYNESS; WELLBEING; WHOLE BODY RADIATION; WOMEN'S HEALTH;

EID: 34447567171     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.3.4.455     Document Type: Review

References (112)

1. Meskhi A, Seif MW. Premature ovarian failure. Curr. Opin. Obstet. Gynecol. 18(4), 418-26 (2006).
2. Graziottin A: Basson R: Sexual dysfunctions in women with premature menopause. Menopause 11(6), 766-777 (2004).
3. Laml T, Schultz-Lobmeyr I, Obruca A et al.: Premature ovarian failure: etiology and prospects. Gynecol. Endocrinol. 14. 292-302 (2000).
4. Anasti JN: Premature ovarian failure: an update. Fertil. Steril. 70, 1-15 (1998).
5. Graziottin A: Sexuality, ageing and chronic diseases: latrogenic premature menopause in cancer survivors. In: Menopause: the State of the Art. Schneider HPG (Ed.). Parthenon Publishing, London. UK, 408-415 (2003).
6. Abdullah RT, Muasher SJ: Surviving cancer, saving fertility: the promise of cryopreservation. Sexuality Reproduct. Menopause 4(1), 7-12 (2006).
7. Leader A: Pregnancy and motherhood: the biological clock. Sexuality Reproduct. Menopause 4(1), 3-6 (2006).
8. Green DM, Zevon MA, Brenda H: Achievement of life goal by adult survivors of modern treatment for childhood cancer. Cancer 67, 206-213 (1991).
9. Puukko, LMR, Hirvonen E, Aalberg V, Hovi L, Rautonen J. Siimes MA: Sexuality in young women surviving leukemia. Arch. Dis. Child. 76, 197-202 (1997).
10. Rauck A, Green DM, Yasui Y, Mertens A, Robinson LL: Marriage in the survivors of childhood cancer: a preliminary study description from the Childhood Cancer Survivor Study Medical and Pediatric. Oncology 33, 60-63 (1999).
11. Fobair P, Hoppe RT, Bloom J, Cox R. Varghese A, Spiegel D: Psychosocial problems among survivors of Hodgkin's disease. J. Clin. Oncol. 4, 806-814 (1986).
12. Schover LR: Sexuality and body image in younger women with breast cancer. J. Natl Cancer Inst. Monogr. 16, 177-182 (1994).
13. Ganz PA. Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L: Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res. Treat. 38, 183-199 (1994).
14. Graziottin A, Castoldi E: Sexuality and breast cancer: a review. In: The Management of the Menopause. The Milliennium Review. Studd J (Ed.). Parthenon Publishing, London, UK. 211-220 (2000).
15. North American Menopause Society: Recommendations for estrogen and progestogen use in peri and postmenopausal women. Menopause 11(6), 589-600 (2004).
16. Skouby SO. EMAS Writing Group: Climacteric medicine: European Menopause and Andropause Society (EMAS) position statements on postmenopausal hormonal therapy. Maturitas 48, 19-25 (2004).
17. Burger H, International Menopause Society Writing group: Practical recommendations for hormone replacement therapy in the peri and post menopause Climacteric 7, 1-7 (2004).
18. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN: Reduced ovarian function in long term survivors of radiation- and chemotherapy-treated childhood cancer. J. Clin Endocrinol. Metab. 88, 5307-5314 (2003).
19. Critchley HO, Bath LE, Wallace WH: Radiation damage to the uterus - review of the effects of treatment of childhood cancer. Hum. Fertil. 5, 61-66 (2002).
20. Broeckel JA, Jacobsen PB, Harton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 16(5), 1689-1696 (1998).
21. Bower JE, Ganz PA, Desmond KA. Rowland JH, Meyerowitz BE, Belin TR: Fatigue in breast cancer survivors: occurrence, correlates and impact on quality of life. J. Clin. Oncol. 18(4), 743-753 (2000).
22. Flay L, Matthews JL: The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 1(2), 399-404 (1995).
23. Graziottin A: Sexual function in women with gynecologic cancer: a review. Int. J. Gynecol. Obstet. 2, 61-68 (2001).
24. Liao KLM, Wood N, Conway GS: Premature menopause and psychological well-being. J. Psychosom. Obstet. Gynecol. 21(3), 167-174 (2000).
25. Singer D, Hunter M: The experience of premature menopause: a thematic discourse analysis. J. Reprod. Infant Psychol. 17(1), 63-81 (1999).
26. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N: Premature menopause in a multiethnic population study of the menopause transition. Hum. Reprod. 8(1), 199-206 (2003).
27. Adamopoulos DA, Karamertzanis MD, Thomopoulos A, Pappa A, Koukkou E, Nicopoulou SC: Age at menopause and prevalence of its different types in contemporary Greek women. Menopause 9(6), 443-448 (2003).
28. Jonat W, Kaufmann M, Sauerbrel W et al.: Goserelin vs. cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: the Zoladex Early Breast Cancer Research Association Study. J. Clin. Oncol. 20(24), 4628-4635 (2003).
29. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z: Fertility preservation in breast cancer patients: in vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod. 18, 90-95 (2003).
30. Oktay K, Buyuk E, Veeeck L et al.: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363, 837-840 (2004).
31. Smitz J: Oocyte developmental competence after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363, 832-833 (2004).
32. Porcu E, Venturoli S: Progress with oocyte cryopreservation. Curr. Opin. Obstet. Gynecol. 18(3), 273-279, (2006).
33. Tilly JL, Kolesnick RN: Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1585(2-3), 135-138 (2002).
34. Alexander JL, Dennerstein L: Burger H, Graziottin A: Testosterone and libido in surgically and naturally menopausal women. Women's Health 2(3), 459-477 (2006).
35. Graziottin A: Sexuality and the menopause. In: The Management of the Menopause - Annual Review. Studd J (Ed.). Parthenon Publishing, London, UK, 49-57 (1998).
36. Bachmann GA, Leiblum SR: The impact of hormones on menopausal sexuality: a literature review. Menopause 11(1), 120-130 (2004).
37. Graziottin A: Psychosexual role of the skin at the climacteric. In: Hormone Replacement Therapy and the Skin. Brincat MP (Ed.). Parthenon Publishing, London, UK, 57-64 (2001).
38. Plaut M, Graziottin A, Heaton J: Sexual Dysfunctions. Health Press, Oxford, UK (2004).
39. Graziottin A: Clinical approach to dyspareunia. J. Sex Marital Ther. 27, 489-501 (2001).
40. Travell JG. Simons DG: Myofascial Pain and Dysfunction, the Trigger Points Manual. The Lower Extremities. Williams & Wilkins. Baltimore, MD, USA (1992).
41. Alexander JL, Kotz LK, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M: The effects of menopausal hormone therapies on female sexual functioning: a review of double-blind randomised controlled trials. Menopause 11 (6 Pt 2). 749-765 (2004).
42. Goldstein I, Alexander JL: Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J. Sex. Med. (2 Suppl. 3), 154-165 (2005).
43. Bachmann GA, Rosen R, Pinn VW et al.: Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J. Reprod. Med. 51(6), 447-456 (2006).
44. Clulow C: Adult Attachment and Couple Psychotherapy. Brunner-Routledge. Hove, UK (2001).
45. Leiblum SR, Rosen R: Principles and Practice of Sexual Therapy. Guilford, NY, USA (2000).
46. Segraves T: Clayton A, Croft H. Wolf A, Warnock J: Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J. Clin. Psychopharmacol. 24(3), 339-342 (2004).
47. Shifren JL, Braunstein J, Simon JA et al.: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. 343, 682-688 (2000).
48. Laan E, van Lunsen RHW, Everaerd H: The effect of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 4, 28-41 (2001).
49. Rioux JE, Devlin MC, Gelfand MM et al.: 17-β-estradiol tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 7(3), 156-161 (2000).
50. Simunic V, Banovic I, Ciglar S, Jeren L, Pavicic Baldani D, Sprem M: Local estrogen treatment in patients with urogenital symptoms. Int. J. Gynecol. Obstet. 82, 187-197 (2003).
51. Dessole S, Rubattu G, Ambrosini G et al.: Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 11(1), 49-56 (2004).
52. Buster JE, Kingsberg SA, Aguirre O et al.: Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial Obstet. Gynecol. 105(5 Pt 1), 944-952 (2005).
53. Davis SR, van der Mooren MJ, van Lunsen RH et al.: Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 13(3), 387-396 (2006).
54. Simon J, Braunstein G, Nachtigall L et al.: Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder J. Clin. Endocrinal. Metab. 90(9), 5226-5233 (2005).
55. Thomson AB, Critchley HO, Kelnar CJ, Wallace WH: Late reproductive sequelae following treatment of childhood cancer and options for fetility preservation. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 6(2), 311-334 (2002).
56. Dennerstein L, Koochaki PE, Barton I, Graziottin A: Hypoactive sexual desire disorder in menopausal women: a survey of Western European women J. Sex. Med. 3, 212-222 (2006).
57. Kalantaridou SN, Calis KA, Vanderhoof VH et al.: Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure Fertil. Steril. 86(5), 1475-1482 (2006).
58. Fassnacht W, Mempel A, Strowitzki T, Vogt PH: Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Curr. Med. Chem. 13(12), 1397-1410 (2006).
59. Elsheikh M, Dunger DB, Conway GS, Wass JA: Turner's syndrome in adulthood. Endocrinol. Rev. 23, 120-140 (2002).
60. Mazzocco MM: Advances in research on the fragile X syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 6(2), 96-106 (2000).
61. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P: Pathophysiology of impaired ovarian function in galactosaemia. Hum. Reprod. Update 12(5), 573-84 (2006).
62. Luborsky J, Lianes B, Davies S, Binor Z, Radwanska E, Pong R: Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin. Immunol. 90(3), 368-374 (2000).
63. Medeiros MM, Silveira VA, Menez AP, Carvalho RC: Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz. J. Med. Biol. Res. 34(12), 1561-1568 (2001).
64. Manger K, Wildt L, Kalden JR, Manger B: Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO Study. Autoimmun. Rev. 5(4), 269-272, (2006).
65. Bagur A, Mautalen C, Findor J, Sorda J, Somoza J: Risk factors in the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif. Tissue Int. 63(5), 385-390 (1998).
66. Gasnault JP, Pagniez I, Sailly F: Long term functional prognosis after ovarian hyperstimulation. A retrospective study. Rev. Fr. Gynecol. Obstet. 94(3), 171-177 (1999).
67. Pines A, Shapira I, Mjiatovic V, Margalioth EJ, Frenkel Y: The impact of HT for infertility on the age at menopause. Maturitas 414, 283-287 (2002).
68. Hauvkik UK, Dieset I, Bjoro T, Holte H, Fossa SD: Treatment related premature ovarian failure as a long term complication after Hodgkin's lymphoma. Ann.Oncol. 17(9), 1428-1433 (2006).
69. Bain C: Managing women with a previous diagnosis of endometriosis. J. Br. Menopause Soc. 12(1), 28-33 (2006).
70. Andrykowski MA: Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant. 13, 357-375 (1994).
71. Federman DD: Three facets of sexual differentiation. N. Engl. J. Med. 350(4), 323-324 (2004).
72. Semmens JP, Wagner G: Estrogen deprivation and vaginal function in postmenopausal women. JAMA 248, 445-448 (1982).
73. Hextall A: Oestrogens, and lower urinary tract function. Maturitas 36, 83-92 (2000).
74. Bachmann G, Bancroft J. Braunstein G et al.: FAI: the Princeton consensus statement on definition, classification and assessment. Fertil. Steril. 77, 660-665 (2002).
75. Wierman ME, Basson R, Davis SR et al.: Androgen therapy in women. J. Clin. Endocrinol. Metab. 91(19), 3697-3716 (2006).
76. Brincat M: Hormone Replacement Therapy and the Skin. Parthenon Publishing. London, UK, 8-20 (2002).
77. Santoro N: Weight gain in midlife: don't blame your hormones. Menopause 7(2), 69-70 (2000).
78. Crawford S, Casey VA, Avis NE, McKinlay SM: A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 7 (2), 96-104 (2000).
79. Bellerose SB, Binik YM: Body image and sexuality in oophorectomized women. Arch. Sex. Behav. 22(5), 435-460 (1993).
80. Asmundson GJG: Anxiety and related factors in chronic pain. Pain Res. Manag. 7(1) 9-20 (2002).
81. Dennerstein L, Randolph J, Taffe J. Dudley E, Burger H: Hormones, mood, sexuality and the menopausal transition. Fertil. Steril. 77, S42-S48 (2002).
82. Northouse LL: Breast cancer in younger women: effects on interpersonal and family relations. Monogr. Natl Cancer Inst. 16, 183-190 (1994).
83. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF: Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85(3), 640-650 (1998).
84. Haddad P, Pitceathly C, Maguire P: Psychological morbidity in the partners of cancer patients. In: Cancer and the Family. Baider L, Cooper CL (Eds). John Wiley & Sons, Chichester, UK. 257-268 (1996)
85. Burger HG: Androgen production in women. Fertil. Steril. 77(4), S3-S5 (2002).
86. Sarrel PM: Androgen deficiency in women: menopause and estrogen-related factors. Fertil. Steril. 77(4). S77-S82 (2002).
87. Graziottin A: Iatrogenic and post-traumatic FSD. In: International Society of Sexual Medicine Standard Committee Book, Standard Practice in Sexual Medicine. Porst H, Buvat J (Eds). Blackwell, Oxford, UK, 351-361, (2006).
88. Doldi N. Belvisi L, Bassan M, Fust FM, Ferrari A: Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol. Endocrinol. 12, 23-28 (1998).
89. Panksepp J: Affective Neuroscience: the Foundation of Human and Animal Emotions. Oxford University Press, Oxford, UK (1998).
90. Solms M, Turnbull O: The Brain and the Inner World. Karnac Books, London, UK, (2002).
91. Miller KK: Androgen deficiency in women. J. Clin. Endocrinol. Metab. 86(6), 2395-2401 (2001).
92. Giraldi A, Graziottin A: Sexual arousal disorders. In: International Society of Sexual Medicine Standard Committee Book, Standard Practice in Sexual Medicine. Porst H, Buvat J (Eds). Blackwell, Oxford, UK, 325-333 (2006).
93. Somboonporn W, Davis S, Seif M, Bell R, Davis S: Testosterone for peri and postmenopausal women. Cochrane Database Syst. Rev. CD004509 (2005).
94. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537-544 (1999).
95. Graziottin A: Sexual pain disorders (dyspareunia and vaginismus). In: International Society of Sexual Medicine Standard Committee Book, Standard Practice in Sexual Medicine. Porst H, Buvat J (Eds). Blackwell, Oxford, UK, 342-350 (2006).
96. O'Connell HE, Hutson JM, Anderson, CR. Plenter RJ: Anatomical relationship between urethra and clitoris. J. Urol. 159, 1892-1897 (1998).
97. Taylor SM, Kinney AM, Kline JK: Menopausal transition: predicting time to menopause for women 44 years or older from simple questions on menstrual variability. Menopause 11(1), 40-48 (2004).
98. Graziottin A, Leiblum SR: Biological and psychosocial etiology of female sexual dysfunction during the menopausal transition. J. Sex. Med. 2(S3), 134-146 (2005).
99. Graziottin A: Breast cancer and its effects on women's self-image and sexual function. In: Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment. Goldstein I, Meston C. Davis S. Traish A (Eds). Taylor and Francis, London UK, 276-281 (2006).
100. Basson R, Leiblum SR, Brotto L et al.: Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J. Psychosom. Obstet. Gynecol. 24(4), 221-229 (2003).
101. Bancroft J. Loftus H, Long JS: Distress about sex: a national survey of women in heterosexual relationships. Arch. Sex. Behav. 32(3), 193-208 (2003).
102. Dew JE, Wren BG, Eden JA: A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 6, 45-52 (2003).
103. Bondy CA, Dimitrakakis C: Androgen and breast cancer risk. In: Menopause: the State of the Art. Schneider HPG (Ed.). Parthenon Publishing, London, UK, 28-35 (2003).
104. Sippila S, Taaffe D, Cheng S et al.: Effects of hormone replacement therapy and high impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. 101, 147-157 (2001).
105. Million Women Study Collaborators: Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362, 419-427 (2003).
106. Holmberg L, Andersen H: HABITS (Hormonal replacement therapy After Breast cancer - Is iT Safe?), a randomized comparison: trial stopped. Lancet 363, 453-455 (2004).
107. Chlebowski RT, Col C: Menopausal hormone therapy after breast cancer. Lancet 363, 410-411 (2004).
108. Jensen PT, Groenvold M, Klee MC, Thranov I. Petersen MA, Machin D: Early stage cervical carcinoma, radical hysterectomy and sexual function, a longitudinal study. Cancer 100(1), 197-206 (2004).
109. Whipple B, Graziottin A: Orgasmic disorders. In: International Society of Sexual Medicine Standard Committee Book, Standard Practice in Sexual Medicine. Porst H, Buvat J (Eds). Blackwell, Oxford, UK, 334-341 (2006).
110. Vincenti E, Graziottin A: Sexual pain disorders: management by anesthetic blocks. In: Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment. Goldstein I, Meston C, Davis S, Traish A (Eds). Taylor and Francis, London, UK, 524-528 (2006).
111. Banner L, Whipple B, Graziottin A: Sexual aversion disorders. In: International Society of Sexual Medicine Standard Committee Book, Standard Practice in Sexual Medicine Porst H, Buvat J (Eds). Blackwell, Oxford, UK, 320-324 (2006).
112. McKee AL, Schover LR: Sexuality rehabilitation. Cancer 92, 1008-1012 (2001).